Givaudan SA (OTCMKTS:GVDNY – Get Free Report)’s stock price passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $78.98 and traded as high as $84.1150. Givaudan shares last traded at $83.1050, with a volume of 14,504 shares trading hands.
Wall Street Analyst Weigh In
A number of analysts have weighed in on GVDNY shares. Zacks Research upgraded Givaudan from a “strong sell” rating to a “hold” rating in a research note on Monday, May 18th. Kepler Capital Markets cut Givaudan from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, May 13th. The Goldman Sachs Group raised Givaudan from a “sell” rating to a “buy” rating in a report on Monday, June 8th. Sanford C. Bernstein began coverage on shares of Givaudan in a research note on Wednesday. They issued an “underperform” rating on the stock. Finally, Barclays cut shares of Givaudan from a “strong-buy” rating to a “hold” rating in a report on Friday, March 27th. Three analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold”.
Read Our Latest Analysis on GVDNY
Givaudan Stock Up 0.5%
Givaudan Company Profile
Givaudan is a Swiss-based global company that develops, manufactures and supplies flavors, fragrances and active cosmetic ingredients for a broad range of consumer products. The company’s core activities are organized around creating taste and scent solutions—ranging from fine fragrances and consumer-packaged goods scents to flavor systems for food and beverages and functional ingredients for personal care. Givaudan works with brand owners and manufacturers to design sensory experiences, improve product performance and meet formulation or regulatory requirements.
Its product and service offerings include bespoke fragrance creation, flavor formulation, natural ingredient sourcing, aroma chemicals, taste modulators and application support such as prototyping and sensory testing.
Featured Stories
- Five stocks we like better than Givaudan
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Receive News & Ratings for Givaudan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Givaudan and related companies with MarketBeat.com's FREE daily email newsletter.
